Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the second ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

The Smith Center for Outcomes Research in Cardiology at BIDMC brings together physicians & researchers to examine pressing ...

Boston Scientific BSX has been gaining from new product launches and accretive acquisitions. International expansion remains ...

Facing White House cuts, New England labs are looking to foundations, industry, and even their university hosts to bankroll ...

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

MARCEL HUG OF SWITZERLAND IS CELEBRATING HIS EIGHTH BOSTON TITLE, HIS FIFTH IN A ROW, CLOCKING IN ONE HOUR 21 MINUTES, 34 SECONDS. HE’S SO GOOD. THERE WERE NO MISHAPS THIS YEAR. MAYBE YOU ...

Fintel reports that on April 16, 2025, Needham upgraded their outlook for Boston Scientific (NYSE:BSX) from Hold to Buy. Analyst Price Forecast Suggests 27.04% Upside As of April 2, 2025 ...

13 analysts have expressed a variety of opinions on Boston Scientific (NYSE:BSX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a ...

We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX. Boston Scientific Corporation ...